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Abstract
A multidisciplinary approach to the treatment of chronic pain has
been one of the most effective means of restoring the ability of a
patient to return to an increased level of function. Many techniques
used for diagnostic and therapeutic means have been utilized as part
of this approach. This paper will describe some of the more common
invasive techniques used in the treatment of chronic pain.
Invasive Techniques Utilized in Chronic Pain
Management
Pain management has received much attention in the media lately
with discussions ranging from physician assisted suicide to narcotic
use in the chronic pain patient. Treatment of the chronic pain patient
is best accomplished with a multidisciplinary approach as pain is a
complex multidisciplinary problem. Proper treatment will often
require input and therapy from anesthesiology, medicine, neurol
ogy, oncology, physiatry, physical and r:dpational therapy, psy
chiatry, psychology, surgery, and nursing services. Some of the
more common treatments which have been performed by the anes
thesiologist will be discussed. These therapies include nerve blocks,
epidural injections, dorsal column stimulators, and subcutaneous
infusion pumps. Many of these techniques are used daily for surgical
anesthesia or post operative pain management. They are also useful
in treatment of various chronic pain syndromes. Invasive therapies
are only one aspect of pain treatments, and other treatment modali
ties will not be described in this article.
The epidural space is a potential space between the dura and the
ligamentum flavum and lamina. It is present from the foramen
magnum to the sacrococcygeal membrane. Injection into the epidu
ral space may occur between any of the vertebra down to the caudal
space. Various medications have been injected into the epidural
space for anesthesia and/or analgesia. These medications include
local anesthetics, narcotics, steroids. Clonidine, neurolytic agents,
autologous blood, and hypertonic saline to name a few. Injections
can be performed as a one time injection, or an epidural catheter may
be placed for continuous infusions. The indications for an epidural
injection in the acute setting include: surgery, obstetrics, postopera
tive pain, fractured ribs, pancreatitis, frostbite, herpes zoster, is
chemic pain, and post dural puncture headaches. Indications for
chronic pain include: low back and cervical pain, postherpedic
neuralgia, chronic regional pain syndrome, malignancy, phantom
limb, and diagnostic orprognostic blockade.’ Epidural injections are
usually placed at the closest dermatome to the level which is
involved with their symptoms. There are various types epidural
needles which can be used. The needle is placed on the midline or
a paramedian approach to the epidural space. Confirmation of the
epidural space may be made by loss of resistance technique or a
hanging drop technique prior to the injection of the agents. Compli
cations associated with this technique, although rare, may be attrib
uted to either the needle placement or the specific agent injected.
Insertion of the needle may injure the epidural veins which may
result in an epidural hematoma, and bacterial contamination may
cause an epidural abscess or meningitis. If these are not recognized
quickly and treated effectively, nerve damage or paralysis may
occur. Injection of local anesthetics may cause hypotension second
ary to sympathetic blockade. Since large volumes are often used, an
unintentional subarachnoid injection may result in a total spinal
anesthetic which would require circulatory and ventilatory support.
Narcotics may cause respiratory depression immediately after injec
tion or delayed respiratory depression up to 12 hours later. Any
medication injected into the epidural space should be preservative
free since most preservatives are considered neurotoxic.
Epidural injections were first reported in 1901 as treatment for
lumbar nerve root compression.2There have been numerous reports
since then trying to delineate indications and efficacy of epidural
steroid injections(ESI). The difficulty and controversy that arises is
due in part to the inability of most researchers to control the
variables. This would include the cause of the symptoms, duration
of symptoms, history of surgical procedure, previous treatments,
and the treatments being evaluated. Even in comparing studies
which are considered to be well designed, the results are inconsis
tent.3 ESIs have been utilized in the treatment of annular tears,
chronic lumbar degenerative disc disease, herniated nucleus pulposa
(HNP) without neurologic deficits, HNP with nerve root irritation,
HNP with nerve root compression, spondylolysis, spondylolisthe
sis, facet arthropathy, scoliosis, ankylosis spondylitis, spinal steno
sis, functional low back pain, and back pain following spine sur
gery.4’5 There have been varying success rates which are nostly
dependent on the cause of the symptoms. Acute radiculopathies
seem to respond to ESIs better than chronic conditions. Success rates
range from 83% to 100% if the symptoms have been present for less
than three months. This decreases to 67% to 81% at six months, and
46% if symptoms have been present greater than a year. This was
reported in uncontrolled studies.6’789”° Dilke reports through a
prospective, randomized, double blind study the efficacy of ESI in
the treatment of patients with disc problems. They had follow up to
six days after the ES! and used a volume of lOmi.” Another
prospective, randomized, double blind study showed no statistical
significance between the ES! and placebo, however, the objective
and subjective feelings of improvement were higher in the ESI
group.’2The difference between these two studies was that 2 ml of
the steroid solution was placed, and follow up evaluation occurred
after two to three days compared to the larger volume and longer
follow up period of Dilke. Complications from ESIs have consis
HAWAII MEDICAL JOURNAL, VOL 59. MARCH 2000
96
tently been shown to be rare. Unintentional dural puncture occurs
1% of the time. Cushing’ syndrome13and congestive heart failure14
have been reported, but these are extremely rare.
Specific nerve root blocks with steroids may be placed with
fluoroscopic guidance. This may be therapeutic as well as diagnos
tic.15 If the patient has reliefof his symptoms with a single nerve root
injection, this would comfirm the level that may require surgical
correction. Peripheral nerve blocks with local anesthetic may be
used for diagnostic purposes prior to surgical, chemical or thermal
neuroablation.’6Neurolysis has been traditionally recommended for
use in patients with life expectancies of less than one year. Chemical
neurolysis may be accomplished with the injection of phenol 6% -
8% in glycerol or alcohol 33% - 100%. The effects of these solutions
may include precipitation of lipoproteins and mucoproteins, disrup
tion of myelin, extraction of cholesterol, and phospholipids, and
coagulation of proteins. Duration of these injections range from
three to six months before regeneration of the nerve tissue. Compli
cations from these injections are usually due to injury to surround
ings structures. Alcohol may be painful during the injection and
cause an alcohol neuritis with high concentration injections. Phenol
may cause convulsions and renal toxicity. Doses are to be kept below
100 mg. Thermal neuroablation includes cryoanalgesia and
radiofrequency ablation. Both of these methods require the insertion
of a probe to apply heat or cold to the neuron. The equipment
required can be costly and requires knowledge of its use.
Radiofrequency techniques will heat the nerve tissue to 60°C - 1000
C for coagulation. Cryoanalgesia will cool the nerve tissue to -60°
C for destruction of the myelin sheath. These techniques have
minimal tissue damaged, lack of neuritis or neuroma formation, and
cryoanalgesia is reversible after three to six months. Difficulties
with these procedures include sensory and motor deficits that are
bothersome to the patient and recurrence of their symptoms.
The sympathetic nervous system is frequently blocked with local
anesthetics in the treatment of various pain syndromes. In addition
to the sympathetic chain which is innervated with fibers from Ti to
L3, there are several distinct ganglia which are of use in the
treatment of pain. These include the stellate ganglion (SG), celiac
plexus (CP), and the hypogastric plexus (HGP). Sympathetic blocks
have been used in the treatment of circulatory insufficiency which
includes Raynaud’s syndrome, arterial embolism, and vasospasm,
chronic regional pain syndrome, herpes zoster, pain due to abdomi
nal malignancies, and phantom limb pain.17
The SG formed from fibers the first thoracic nerve and occasion
ally the second thoracic nerve, it provides sympathetic innervation
to the head and upper extremity. The ganglion lies in front of the
transverse process of the seventh cervical vertebra. The block is
usually performed at the transverse process of the sixth cervical
vertebra to minimize the risk of puncture to the vertebral artery and
the dome of the pleura. Injection of 10 ml to 20 ml of local anesthetic
is adequate for blockade of the SG. Homer’s syndrome, ptosis,
myosis, and enophthalmos, will indicate sympathetic blockade to
the head, but not necessarily the upper extremity. Complications of
this block may include temporary hoarseness, brachial plexus block,
pneumothorax, verebral artery injection, seizures, hematoma, sub
arachnoid block, and injury to any of the surrounding anatomical
structures.
The celiac plexus is made up of one to five discreet ganglia which
derives its innervation from T5 to Tl2. It provides sympathetic
innervation to the abdominal viscera, stomach, small bowel, large
bowel to the splenic flexure, omentum, liver, gallbladder, pancreas,
spleen, adrenal glands, and kidneys. The CP is located anterior to the
aorta at the level of the celiac artery which corresponds to the Tl2
or Li level. Blockade may be performed from an anterior or
posterior approach. This may be accomplished by using anatomical
landmarks, fluoroscopy, or CT guidance. injection of 30 ml to 50 ml
of local anesthetic will be sufficient to block the celiac plexus for
diagnostic purposes. Neurolytic blocks with alcohol or phenol may
be placed with CT guidance with greater precision. The classic
example for this is the use of a neurolytic CP block in the treatment
of pain associated with pancreatic cancer. Complications which
may occur are diarrhea, hypotension, aortic or vena caval injection,
renal puncture, and hematoma.
The HGP are formed from fibers from and lumbar sympathetic
chain and aortic ganglia. It provides sympathetic innervation to the
rest of the colon and the pelvic contents. The HGP is the most diffuse
of the ganglia. It is located at the bifurcation of the common iliac
arteries which is located at L5. Blockade of the HGP may be
performed using anatomical landmarks, fluoroscopy, or CT guid
ance. Uterine or rectal pain due to unresectable malignancies have
been treated effectively with this procedure.
The sympathetic chain itself, may be blocked with fluoroscopic
guidance to the appropriate level to affect the ipsilateral side.
Lumbar sympathetic blocks with 15 mlto 20 ml of local anesthetic
are the most frequent block of this type This would be effective in
treating disorders of a single lower extremity. The blockade of a
single extremity may be beneficial in the patient who would not
tolerate complete sympathetic blockade of both lower extremities
that can occur with an epidural or subarachnoid block.
Chronic regional pain syndrome (CRPS), formerly referred to as
reflex sympathetic dystrophy or sympathetic mediated pain is an
uncommon pain syndrome which usually affects the extremities.
CRPS may occur after an injury to the limb. The patient will develop
a burning sensation which may or may not follow a specific nerve
distribution. They will have hyperpathia, increased sensitivity, and
allodynia, pain to a stimulus which is normally without pain. The
affected limb has decreased blood flow which may result in de
creased temperature and cyanosis. Eventually, there will be loss of
hair and skin changes associated with ischemia. The limb becomes
painful to move, and even wind blowing on the limb will cause
excruciating pain. This leads to immobility, contractures, and loss of
bone density. Treatments are aimed at early diagnosis and early
aggressive treatment.18 Sympathetic blocks or IV regional blocks
with Guanethidine or Bretylium have been used as treatments for
CRPS. Clonidine, an alpha-2 agonist, has also been used with
success. Other treatments for neuropathic pain such as the antide
pressant and anticonvulsant medications have been used. Physical
therapy is an integral part of the patient’s care to maintain range of
motion and strength. If these modalities fail, implantable devices
may be considered.
With advances in technology, dorsal column stimulators (DCS)
have become a good therapeutic option in some patients. This may
help to prevent a neuroablative procedure. DCS has been utilized in
the treatment of failed laminectomies, CRPS diabetic neuropathy,
ischemic pain and PHN.’9 Candidates for this therapy will have
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failed other more conservative modalities including oral pharmaco
therapy, nerve blocks, and TENS. Proper patient selection will be
made prior to the implantation with the patient’s pain pattern being
at the center of this evaluation. A OCS electrode has one to eight
leads on it, each of which can be programmed positive, negative, or
off. The generator itselfmay also be programmed as one of the leads.
The electrode may be placed percutaneously or via a
hemilaminotomy. Final position will be attained with fluoroscopic
guidance and verbal confirmation with the patient. The patient will
have a trial of the DCS for one to two weeks. They should have at
least a 50% reduction in their symptoms before deciding on the final
placement of the subcutaneous generator. In this regard, there are
two systems available. One is completely subcutaneous with the
pulse generator/battery unit implanted on the abdominal wall or
buttock. There is an external hand held unit to turn the DCS on, off,
up, or down within the preprogrammed variables. The other system
type has a generator coil implanted subcutaneously with an external
telemetry Unit to provide the energy for stimulation. The external
unit will utilize 9 volt batteries. Once the electrode has scarred in
place, there should be minimal maintenance of the system. The
patient should return to physical therapy for rehabilitation.
When the pain pattern covers more than several dermatomes, a
DCS would be only partially effective. Spinal opioids would be next
in the line of treatment modalities from less invasive to more
invasive. Opioids administered into the epidural or intrathecal space
have provided analgesia which is superior to that of parenterally
administered opioids.2°Neuraxial opioids have been used in post
operative pain, cancer pain, herpes zoster, myocardial infarction,
thrombophlebitis, ischemic pain, low back pain, obstetrics, and
chronic regional pain syndrome to name a few. Intrathecal and
epidural infusion will use much less medication than the oral route.
Patients who were unable to take large doses of narcotics due to side
effects may be able to tolerate the lower doses with improved pain
relief.2122 Selection of the narcotic to be used is based on the
pharmacodynamics and pharmacokinetics of the narcotic in the
intrathecal or epidural space. Onset of action is shorter it the narcotic
is more lipophilic, such as Fentanyl.
Morphine is a more hydrophilic narcotic and has a slower onset of
action and longer duration of action that the other opioids. Neuraxial
opioids may be administered as single shot doses or continuously
through a catheter. Adverse effects ofspinal opioids may occur at the
time of injection. Epidural doses are larger than intrathecal doses by
10 to 16 times, and systemic side effects are more likely in the
epidural route. Nonsystemic effects more commonly associated
with neuraxial opioids are urinary retention, pruritis, and delayed
respiratory depression. Pruritis can be treated effectively with
antihistamines or naloxone. This usually disappears after several
days. Naloxone and/or catheterization may be used in treating
urinary retention. Early respiratory depression may occur from
systemic absorption of opioids. Delayed respiratory depression may
occur hours after administration of neuraxial opioids due to rostra!
spread in the cerebral spinal fluid. Although this is very rare, it is
more common with hydrophilic narcotics compared to the more
lipophilic narcotics. This is easily treated with small doses of
Naloxone.
An epidural catheter maybe tunnelled subcutaneously to decrease
the incidence of infection, or it may be attached to a subcutaneous
port. The intrathecal catheter may be connected to a subcutaneous
infusion pump (SCIP). Narcotics are usually infused through these
systems. Other medications such as Baclofen, Clonidine, and local
anesthetics have also been placed in the epidural or intrathecal space
via a SCIP. An epidural port infusion would require an external
infusion pump and larger volumes with refills one to two times a
week. An intrathecal infusion with a SCIP may be refilled every
three months. The main consideration in choosing an epidural
catheter with a subcutaneous port or intrathecal catheter with a
subcutaneous infusion pump would be the life expectancy of the
patient. Both modalities are very effective, but the cost of each
system varies. The epidural and port system is inexpensive initially,
but with time, the cost of medication, supplies, and nursing support
will become greater than the cost of the subcutaneous infusion
pump. These cost lines cross at approximately three months time. A
patient with a life expectancy of three to six months should have an
epidural catheter with a port, and a life expectancy of greater than
three months should have the intrathecal catheter and subcutaneous
infusion pump.
There are many options in the treatment of chronic pain. The
majority of patients will respond to the more traditional therapies of
oral pharmacotherapy or surgical correction of an anatomic abnor
mality that causes the pain. Up to 20% of patients will not respond
well to these therapies. If these methods are ineffective or they cause
adverse reactions, there are other treatment modalities available.
Knowledge of these modalities will help to insure the adequate and
compassionate care of the patient with intractable pain.
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